eu review of legislation on veterinary medicinal products in july 2018 argentina raised concerns regarding the european unions proposed regulation on veterinary medicinal products stating that the adoption of provisions regarding the use of antimicrobials in the veterinary sector would have a significant impact on international trade. argentina reiterated its commitment to the fight against amr its active participation in codex alimentarius and oie work and its conviction that an appropriate solution should be reached by consensus within a multilateral setting in a manner compatible to the wto sps agreement. argentina was concerned that the proposed text which was to be formally adopted by the european parliament and the council of europe would require exporters of animals and animal products to meet eu standards concerning the use of certain antimicrobial medicinal products as well as specific usage provisions as a condition for maintaining access to the eu market despite the differences in the prevailing sanitary conditions. argentina further added that recommendations from international organizations such as codex alimentarius did not suggest that measures of this type should be taken with regard to antimicrobials which implied a lack of certainty as to the results that could be achieved through these measures a lack of scientific basis and a disproportionate reaction to the risk. argentina contended that the provisions that the european union deemed appropriate to resolve sanitary matters specific to the european union and its regions could not be applied on an extraterritorial basis to countries that did not share the same sanitary conditions. further through this new regulation the european union would be applying a reciprocity approach that lacked scientific basis preventing access to the eu market for animal products from third countries where antimicrobial medicinal products were subject to different usage authorization standards. argentina requested the european union to consider the equivalence of third country regulations on the use of antimicrobial medicines in the veterinary sector based on rigorous scientific assessment vis-a-vis the level of sanitary protection set by the european union clarify the criteria used to list antimicrobial medicinal products to which this reciprocity policy would apply and take appropriate steps to avoid undue restrictions on international trade of animals and foods of animal origin as a consequence of the application of new provisions on the use of antimicrobial medicinal products in the veterinary sector. the united states shared this concern emphasising that the measure would require foreign producers to abide by eu production methodology requirements related to antibiotic use restrictions in livestock and would not target residues of concern or the presence of resistance genes. the united states also informed the committee that it had joined several wto members in addressing concerns over this measure in a joint letter to eu commission president juncker. the eu restrictions would require other members to adopt essentially the same comprehensive eu regulatory programme without taking into consideration different conditions present in their territories. applied extraterritorially these restrictions would undermine multilateral efforts to combat amr such as those undertaken through the codex task force on antimicrobial resistance established to develo science-based guidelines on the management of foodborne amr and to consider development of guidance on integrated surveillance of amr among others. in light of the ongoing multilateral efforts to develo standards on amr the united states urged the european union to delay the adoption of new legislation until the guidelines were made available by codex. colombia shared the concern and thanked the european union for the information provided under item 3 a iii . chile also expressed interest in this topic given its potential consequences for int